Canopy Growth Corporation (TSX: WEED) (“Canopy Growth” or “the Company”) today released its financial results for the fourth quarter and fiscal year 2017, the period ended March 31, 2017. All financial information in this press release is reported in Canadian dollars, unless otherwise indicated.
- Consolidated revenues increased 28% for the quarter and 65% for the year-to-date [up 3% on a pro forma basis(1) for the quarter and down 2% for the year-to-date(1)]
- Consolidated segment profit(2) growth of 35% for the quarter and 54% for the year-to-date [up 14% on a pro forma basis(1) for the quarter and up 5% for the year-to-date(1)]
- Consolidated segment profit margin (2) of 38% for the quarter and 36% for the year-to-date
- Net income attributable to shareholders of $66.7 million ($0.33 per share basic) for the quarter and $162.7 million ($0.81 per share basic) for the year-to-date.
- Adjusted basic earnings per share(2)(3) of $0.35 per share for the quarter
New York-based hedge fund Paulson & Co on Monday reported a 6.3 percent stake in embattled Canadian drugmaker Valeant Pharmaceuticals International Inc (VRX.TO) (VRX.N).
Cannabis Wheaton Income Corp. (TSX VENTURE:CBW) (“Cannabis Wheaton” or the “Company“) is pleased to announce that the Company and Mackie Research Capital Corporation acting as lead agent and sole bookrunner have agreed to revise the size of the previously announced best efforts private placement of Special Warrants and Convertible Debenture Units, from up to $50,000,000 to up to $60,000,000 plus a 15% over-allotment option.
Earlier this week, Canopy Growth Corporation (TSX: WEED) (“Canopy Growth” or the “Company”) provided a global operational update to keep shareholders and other stakeholders apprised of operational developments as they relate to international milestones and innovative new product types. With a rapidly growing medical market in Canada, increasing international demand profiles and the fast-approaching move towards an adult-use access market in Canada, a reliable, diversified and exponentially larger footprint will be essential.
American Hotel Income Properties REIT LP (“AHIP”) (TSX: HOT.UN) (TSX: HOT.DB.U) (OTCQX: AHOTF) announced today the completion of the previously announced acquisition of a geographically-targeted portfolio of 18 premium branded Marriott and Hilton hotels (the “Acquisition”) containing 2,187 guestrooms and located in Maryland, New Jersey, New York, Connecticut and Pennsylvania (collectively, the “Eastern Seaboard Portfolio”) for approximately US$407.4 million, including brand-mandated property improvement plans (the “PIPs”). Continue reading American Hotel Income Properties REIT Completes Its Transformative U.S. Acquisition
CIBC (TSX: CM) (NYSE: CM) today announced that it has completed the acquisition of Chicago-based PrivateBancorp, Inc. and its subsidiary, The PrivateBank.
Concordia International Corp. (the “Company”) (NASDAQ: CXRX) (TSX: CXR), an international specialty pharmaceutical company focused on generic and legacy pharmaceutical products, today announced an update on the development of its long-term growth strategy. Continue reading Concordia International Corp. Provides Update on Development of Long-Term Growth Strategy
Berkshire Hathaway Inc. (NYSE: BRK.A; BRK.B) (“Berkshire”) announced today that its wholly-owned subsidiary, Columbia Insurance Company (“Columbia”), has entered into an investment agreement (the “Investment Agreement”) pursuant to which it has Continue reading Berkshire Hathaway Announces Agreement to Invest in Home Capital
Valeant Pharmaceuticals International, Inc.’s (NYSE: VRX and TSX: VRX) wholly owned subsidiary, Bausch + Lomb, a leading global eye health company, today announced that Bausch + Lomb contact lens solutions have been named the most trusted contact lens solution brand for the second consecutive year in Canada by BrandSpark International.
Shares of Sears Canada (TSX:SCC) fell 22.50 per cent, or 18 cents, to 62 cents on the Toronto Stock Exchange at market close today. Continue reading Sears Canada shares plunge on rumours of bankruptcy